Search
forResearch 10 of 164
- PSS21 GAP ANALYSIS FOR PATIENT-REPORTED OUTCOMES MEASURES FOR ALOPECIA
- PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS
- Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions
- Hair Care Cosmetics Regulation in Different Countries – A Comparative Study
- Practical and Theoretical Distinctions between Drugs and Cosmetics
- Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
- Mesothelial Stem Cells and Stromal Vascular Fraction for Skin Rejuvenation
- The role of androgens in hormone replacement therapy
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →